Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eratex Djaja Tbk. (ERTX) vs Indofarma Tbk. (INAF) Price & Performance

Eratex Djaja Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Eratex Djaja Tbk. vs Indofarma Tbk. — how do they compare? Eratex Djaja Tbk. trades at Rp181 (market cap 239.3B, 594.1K 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

ERTXINAF
Market Cap
239.3B390.51B
Volume
594.1K
Lot
5.94K
Turnover
108.21M
Average Price
182.14
Value
108.21M
Indicative Equilibrium Price
181
Indicative Equilibrium Volume
864

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ERTX
View details
INAF
View details

About Eratex Djaja Tbk.

PT Eratex Djaja Tbk (the "Entity") was established in the framework of Foreign Capital Investment Law No.1, 1967 by Notarial Deed No.7 dated October 12, 1972 based on Deed prepared by Koerniatini Karim, Public Notary in Jakarta. Founded in 1972 as a joint venture company between PT Private Development Finance Company of Indonesia Ltd. and Limmen Investment Ltd., Unisouh Holding Ltd., Eastern Cotton Mills Ltd. Yarn spinning factory was built in 1973 on 17 ha of land in Probolinggo.

Read more on ERTX

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF